CPH News and Events

A lot of life happens in 99 years. Lois Jean Fenoglio is hoping that some of her 99 years (and counting!) of life experiences can help researchers better understand connections between DNA and health. Fenoglio is participating in the OneDukeGen Genomic Sequencing Study and Biorepository. By providing a blood sample, Fenoglio’s DNA and other material will be analyzed and used in research related to a variety of diseases and conditions.

Resting heart rate measured with an investigational watch worn during the Project Baseline Health Study correlated strongly with electrocardiography (ECG), considered the gold standard.

A unique collaboration launched four years ago between CTSI and Durham Technical Community College continues to thrive and recently welcomed the latest cohort of the Clinical Research Equity Scholars Program.

Pulse oximetry has long been trusted as a key diagnostic tool. However, for patients with darker skin tones, this technology may not be accurate. A new grant aims to fix that.

Opeyemi Olabisi is among the 2025 researchers elected to the American Society for Clinical Investigation (ASCI), one of the nation’s oldest medical honor societies.

Using Genetic Tools to Prevent Disease

Affiliate Duke CTSI faculty members Keisha Bentley-Edwards, PhD, and Senthil Selvaraj, MD, have been named to the 2025 Office for Faculty leadership programs at Duke University School of Medicine.

Early in her career as a breast surgical oncology fellow, Hwang questioned the standard practice of treating patients diagnosed with ductal carcinoma in situ (DCIS) — a small cluster of abnormal cells in breast ducts — with mastectomies or lumpectomies, often followed by radiation.

The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast cancer after two years than women who undergo surgery to remove them.

The Center for Precision Health has welcomed Opeyemi Olabisi, MD, PhD, associate professor of medicine. Olabisi's research focuses on APOL1 variants that contribute to the progression of kidney disease. His ultimate goal is to translate his findings into improved diagnostic and treatment approaches for chronic kidney disease. As a clinician, Olabisi cares for individuals with various degrees of kidney disease. He is passionate about raising awareness about kidney disease and introduce remedies that could slow the progression of kidney disease.